Active ingredientMepivacaine HydrochlorideCat. No. P-M052-001CAS 1722-62-9Family · Pharmaceutical analytical standards
Mepivacaine
An amide-type local anaesthetic synthesised in Sweden in 1957 by chemists Ekenstam and Pettersson and introduced in the United States in the 1960s: it acts quickly and has a medium duration. This family brings together the active ingredient, pharmacopoeial impurities, labelled standards and other impurities.
Did you know?It is used as an equal mixture of two mirror-image forms, the R and S enantiomers, which behave quite differently in the body.
Go to the active ingredient →Active ingredientMepivacaine HydrochlorideCat. No. P-M052-001CAS 1722-62-9
Pharmacopoeial impurityMepivacaine EP Impurity D HClCat. No. P-M052-003
Pharmacopoeial impurityMepivacaine EP Impurity ECat. No. P-M052-004CAS 2717331-30-9
Isotopically labelled3-Hydroxy Mepivacaine-d3Cat. No. P-M052-005CAS 1346597-79-2
Isotopically labelledMepivacaine-d3Cat. No. P-M052-006CAS 1346597-90-7
Impurity3-Hydroxy MepivacaineCat. No. P-M052-007CAS 37055-90-6
ImpurityMepivacaine Impurity 1Cat. No. P-M052-008
ImpurityMepivacaine N-oxideCat. No. P-M052-009CAS 1346597-75-8No product matches your search.
EDQM standards 2
The official European Pharmacopoeia standards for this family.
Reference substanceMepivacaine hydrochloride CRSEDQM code M0370000Family Mepivacaine
ImpurityMepivacaine impurity B CRSEDQM code M0370020Family MepivacaineNeed a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.